Boston Scientific (BSX)
105.26
+0.76 (0.73%)
NYSE · Last Trade: Jun 1st, 8:22 AM EDT

Boston Scientific Corp (NYSE:BSX) combines strong earnings momentum, expanding margins, and a bullish technical setup, making it a candidate for high-growth investors.
Via Chartmill · May 31, 2025

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
Via StockStory · May 30, 2025

Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.
Via Investor's Business Daily · May 29, 2025

Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to meet 2025 sales.
Via Benzinga · May 28, 2025

The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions.
Via Stocktwits · May 28, 2025

The company said the regulatory path forward for one of its key systems is too murky to pursue.
Via Investor's Business Daily · May 28, 2025
Boston Scientific Corp (NYSE:BSX) shows strong growth fundamentals and a bullish technical setup, making it a compelling candidate for growth investors.
Via Chartmill · May 26, 2025
Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season.
Via StockStory · May 25, 2025
Via Benzinga · May 20, 2025
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.
Via Chartmill · May 20, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a candidate for momentum investors.
Via Chartmill · May 19, 2025
Via Benzinga · May 16, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) shows strong technicals and a high-quality setup, making it a breakout candidate. The stock has outperformed peers and exhibits bullish patterns with clear support and resistance levels.
Via Chartmill · May 13, 2025
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence.
With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
Via StockStory · May 13, 2025
A fundamental and technical analysis of (NYSE:BSX): Should you consider BOSTON SCIENTIFIC CORP (NYSE:BSX) for high growth investing?
Via Chartmill · May 9, 2025
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Via StockStory · May 5, 2025
Via Benzinga · May 1, 2025
See these three stocks that beat on earnings in Q1 and raised their guidance for the rest of 2025. These stocks are signaling strength amid tough conditions.
Via MarketBeat · April 29, 2025
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · April 29, 2025
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC)
will be reporting earnings tomorrow before market hours. Here’s what to expect.
Via StockStory · April 29, 2025
Dental technology company Align Technology (NASDAQ:ALGN)
will be reporting results tomorrow after market close. Here’s what you need to know.
Via StockStory · April 29, 2025
Medical tech company CONMED (NYSE:CNMD)
will be reporting earnings tomorrow after market close. Here’s what you need to know.
Via StockStory · April 29, 2025
A fundamental and technical analysis of (NYSE:BSX): Delving into BOSTON SCIENTIFIC CORP (NYSE:BSX)'s high Growth Prospects.
Via Chartmill · April 28, 2025